{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-120698","form_type":"8-K","ticker":"NVAX","cik":"0001000694","company_name":"NOVAVAX INC","filed_at":"2024-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.288066+00:00","generated_at":"2026-05-29T21:31:23.698449+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Novavax to present corporate update at Jefferies London Healthcare Conference","bullets":["Presentation scheduled for November 20, 2024; no specific numbers or details included in the filing or attached exhibit.","Form 8-K and Exhibit 99.1 contain only forward-looking cautionary language and generic strategic update references.","No financial guidance, partnership announcements, or operational metrics provided in the furnished materials.","Investors directed to company website for full presentation materials."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-120698","json":"https://secwatch.observer/filing/0001104659-24-120698.json","markdown":"https://secwatch.observer/filing/0001104659-24-120698.md","text":"https://secwatch.observer/filing/0001104659-24-120698.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924120698/0001104659-24-120698-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924120698/tm2428940d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T21:31:23.698449+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}